Seizure - grand mal
Methodology & AI Transparency ⓘ
Seizure - grand mal Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Cataloged under federal diagnostic code G40.409 in Epilepsy & Seizures, Seizure - grand mal requires epilepsy-protocol 3-Tesla brain in Seizure - grand mal (G40.409: MRI) so specialists can calibrate treatment intensity against Comprehensive Metabolic & in Seizure - grand mal (G40.409: Sodium/Mg Panel) benchmarks.
- 2 Real-world patient consensus: Diagnostic registry G40.409: Seizure - grand mal is managed within Epilepsy & Seizures.
- 3 Typical cash cost range: Primary evaluation for Seizure - grand mal incorporates epilepsy-protocol 3-Tesla brain in Seizure - grand mal (G40.409: MRI) and symptom diary review.
- 4 Top reported side effects / signs: Follow-up benchmark in Seizure - grand mal: maintaining Comprehensive Metabolic & in Seizure - grand mal (G40.409: Sodium/Mg Panel) within Na+ 137–143 mEq/L; Mg 2.0–2.4 mg/dL (G40.409).
Ask our AI Specialists anything about Seizure - grand mal
What Is Seizure - grand mal?
Cataloged under federal diagnostic code G40.409 in Epilepsy & Seizures, Seizure - grand mal requires epilepsy-protocol 3-Tesla brain in Seizure - grand mal (G40.409: MRI) so specialists can calibrate treatment intensity against Comprehensive Metabolic & in Seizure - grand mal (G40.409: Sodium/Mg Panel) benchmarks.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Seizure - grand mal (code G40.409) is thalamocortical network synchronization in Seizure - grand mal (G40.409: or focal structural/metabolic), which Epilepsy & Seizure Disorders clinicians address while surveilling Comprehensive Metabolic & in Seizure - grand mal (G40.409: Sodium/Mg Panel) (Na+ 137–143 mEq/L; Mg 2.0–2.4 mg/dL (G40.409)).
Common Symptoms & Clinical Signs
- • Presentation of Seizure - grand mal (G40.409): rhythmic tonic-clonic jerking in Seizure - grand mal (G40.409: followed by post-ictal)
- • Secondary Seizure - grand mal clinical sign: brief focal sensory in Seizure - grand mal (G40.409: aura, deja-vu sensation,)
- • Symptom flares in Seizure - grand mal correlating with Comprehensive Metabolic & in Seizure - grand mal (G40.409: Sodium/Mg Panel) deviation outside Na+ 137–143 mEq/L; Mg 2.0–2.4 mg/dL (G40.409)
- • Functional epilepsy & seizures impact requiring epilepsy-protocol 3-Tesla brain in Seizure - grand mal (G40.409: MRI) evaluation (G40.409)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Seizure - grand mal Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G40.409 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Epilepsy & Seizure Disorders | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Comprehensive Metabolic & in Seizure - grand mal (G40.409: Sodium/Mg Panel) | Na+ 137–143 mEq/L; Mg 2.0–2.4 mg/dL (G40.409) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Electroencephalogram (EEG) [Seizure - grand mal G40.409] | Absence of epileptiform discharges (G40.409) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Antiseizure Medication Trough in Seizure - grand mal (G40.409: Level) | Agent-specific therapeutic window (G40.409) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Seizure - grand mal
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Clonazepam Klonopin • RxCUI 197528 | Benzodiazepine | 83% | $0.0378 | $ 10.03 /mo |
| Primidone Mysoline • RxCUI 96304 | Anti-epileptic Agent | 87% | $0.0914 | $ 6.19 /mo |
| Klonopin (Clonazepam) Klonopin • RxCUI RXN-B61269620 | Benzodiazepine | 90% | $3.8766 | $ 287.61 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Seizure - grand mal)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Long-term real-world benefits and safety of adjunctive perampanel in patients: What a 704-Participant Study Found The Intent-to-Treat Analysis Set included 704 patients (529 received perampanel and 175 received placebo during the Core Study; all patients received perampanel during OLEx). Epilepsia open • 2024-04-15 • Phase III Randomized Trial | N = 704 | 93/100 | PMID 37867420 ↗ |
| Can This Approach Help? Inside the Latest Research on Dravet syndrome seizure frequency and clustering: Placebo-treated patients in Post-hoc analyses suggested that potential relationships could exist between BMI, age and convulsive seizure cluster variation. Epilepsy & behavior : E&B • 2024-06-15 • Phase III Randomized Trial | N = 35 | 88/100 | PMID 38643658 ↗ |
| Can This Approach Help? Inside the Latest Research on Long-term effects of adjunctive eslicarbazepine acetate in adult Asian patients In summary, adult Asian patients with refractory focal seizures were responsive to treatment with ESL as add-on treatment and generally showed treatment tolerance well for up to 3 years. Clinical and translational science • 2024-05-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38787305 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of adjunctive perampanel in patients with focal seizures or 128 patients (placebo, n = 39; perampanel, n = 89) were included in the gold-standard blind Safety Analysis Set and 126 (FS, n = 113 [placebo, n = 32; perampanel, n = 81]; FBTCS, n = 35 [placebo, n = 14; perampanel, n = 21];... Epilepsia open • 2021-03-15 • Phase III Randomized Trial | N = 39 | 88/100 | PMID 33681652 ↗ |
| Can This Approach Help? Inside the Latest Research on Benefits and safety of perampanel in patients with seizures associated with Seventy patients were randomized into the Core Study (perampanel, n = 34; placebo, n = 36), and 58 entered the Extension. Epilepsia • 2025-02-15 • Phase III Randomized Trial | N = 34 | 88/100 | PMID 39576191 ↗ |
Seizure - grand mal Patient Community & “People Like Me” Threads
Filter Seizure - grand mal community threads and patient logs by age, biological sex, dosage, and treatment duration.